Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 22, Issue 8, 2003, Pages 908-913

  Verleden, Geert M ^a   Dupont, Lieven J ^a   Van Raemdonck, Dirk ^a   Vanhaecke, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; NITRIC OXIDE; TACROLIMUS;

ADULT; ARTICLE; BRONCHIOLITIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFLAMMATION;

EID: 0043167819     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00815-X     Document Type: Article

References (25)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the international society for heart and lung transplantation eighteenth official report - 2001 . J Heart Lung Transplant. 20:2001;805-815.
2. Tamm M., Sharples L., Higenbottam T., Steward S., Wallwork J. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation. Transplant Int. 9:(suppl1):1996;S299-S302.
3. Van den Berg J.W., Geertsma A., van der Bij W., Koeter G.H., de Boer W.J., Postma D.S., ten Vergert E.M. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med. 161:2000;1937-1941.
4. Valentine V.R., Robbins R.C., Berry G.J., Patel H.R., Reichenspurner H., Reitz B.A., Theodore J. Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant. 15:1996;371-383.
5. Verleden G.M. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment. Monaldi Arch Chest Dis. 15:2000;140-145.
6. Cooper J.D., Billingham M., Egan T., Hertz M.I., Higenbottam T., Lynch J., Maurer J., Paradis I., Patterson G.A., Smith C., et al. A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant. 12:1993;713-716.
7. Verleden G.M., Dupont L.J., Lamont J., Buyse B., Delcroix M., Van Raemdonck D., Lerut T., Vanhaecke J., Demedts M.G. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection? J Heart Lung Transplant. 17:1998;231-232.
8. Fisher A.J., Gabbay E., Small T., Doig S., Dark J.H., Corris P.A. Cross-sectional study of exhaled nitric oxide levels following lung transplantation. Thorax. 53:1998;454-458.
9. Verleden G.M., Dupont L.J., Delcroix M., Van Raemdonck D., Vanhaecke J., Lerut T., Demedts M.G. Exhaled nitric oxide (eNO) and lung transplantation impact of the native lung . Eur Respir J. 18:(suppl33):2001;179s.
10. Verleden G.M., Delcroix M., Buyse B., Dupont L. Exhaled nitric oxide (eNO) after lung transplantation (LTx) a prospective study . J Heart Lung Transplant. 20:2001;208.
11. Verleden GM, Dupont LJ, Delcroix M, Van Raemdonck DE and the Leuven Lung Transplant Group. Accuracy of eNO measurements for the diagnosis of chronic rejection after lung transplantation. J Heart Lung Transplant 2003;22(Suppl 1):S182.
12. de Soyza A., Fisher A.J., Small T., Corris P.A. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med. 164:2001;1209-1212.
13. Estenne M, Maurer J, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
14. Verleden G.M. Chronic allograft rejection (obliterative bronchiolitis). Sem Respir Crit Care Med. 22:2001;551-557.
15. Kharitonov S.A., Alving K., Barnes P.J. Exhaled and nasal nitric oxide measurements recommendations (ERS task force report) . Eur Respir J. 10:1997;1683-1693.
16. Husain A.N., Siddiqui M.T., Holmes E.W., Chandrasekhar A.J., McCabe M., Radvany R., Garrity E.R. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 159:1999;829-833.
17. Gabbay E., Walters H., Orsida B., Whitford H., Ward C., Kotsimbos T.C., Snell G.I., Williams T.J. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med. 162:2000;2182-2187.
18. Gabbay E., Walters E.H., Orsida B., Whitford H., Ward C., Kotsimbos T.C., Snell G.I., Williams T.J. In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS. Am J Respir Crit Care Med. 1609:1999;2093-2099.
19. Romanska H.M., Ikonen T.S., Bishop A.E., Morris R.E., Polak J.M. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease. J Pathol. 191:2000;71-77.
20. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., Hoffman J.M., Grisham M.B. Role of nitric oxide in inflammation. Acta Physiol Scand. 173:2001;113-118.
21. Shiraisi T., De Meester S.R., Worrall N.K., Ritter J.H., Misko T.P., Ferguson T.B. Jr, Cooper J.D., Patterson G.A. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J Thorac Cardiovasc Surg. 110:1995;1449-1460.
22. Kaibori M., Sakitani K., Oda M., Kamiyama Y., Masu Y., Nishizawa M., Ito S., Okumura T. Immunosuppressant FK 506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol. 30:1999;1138-1145.
23. Dusting G.J., Akita K., Hickey H., Smith M., Gurevich V. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. Br J Pharmacol. 128:1999;337-344.
24. Mohamed M.A., Robertson H., Booth T.A., Balupuri S., Gerstenkorn C., Kirby J.A., Talbot D. Active TGF-betal expression in kidney transplantation a comparative study of cyclosprin A (CyA) and tacrolimus (FK506) . Transplant Int. 13:(suppl1):2000;s295-298.
25. Elssner A., Jaumann F., Dobman S., Behr J., Schwaiblmair M., Reichenspurner H., Furst H., Briegel J., Vogelmeier C. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome proinflammatory role of bronchial epithelial cells . Transplantation. 70:2000;362-367.